Loading…
Intelligent Bio Solutions Inc. is projected to decline to $1.65 by 2027, a -9% move from its current price of $1.82. INBS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.74 | $1.82 | $1.90 | -0.03% |
| Aug 6 | $1.71 | $1.82 | $1.94 | -0.06% |
| Aug 7 | $1.68 | $1.82 | $1.96 | -0.08% |
| Aug 8 | $1.66 | $1.82 | $1.99 | -0.11% |
| Aug 9 | $1.65 | $1.82 | $2.01 | -0.14% |
| Aug 10 | $1.63 | $1.82 | $2.02 | -0.17% |
| Aug 11 | $1.62 | $1.82 | $2.04 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.62 | $1.82 | $2.04 | -0.19% |
| Week 2 | $1.54 | $1.81 | $2.14 | -0.39% |
| Week 3 | $1.48 | $1.81 | $2.22 | -0.58% |
| Week 4 | $1.43 | $1.81 | $2.28 | -0.78% |
| Week 5 | $1.39 | $1.80 | $2.34 | -0.97% |
| Week 6 | $1.35 | $1.80 | $2.39 | -1.16% |
| Week 7 | $1.32 | $1.80 | $2.45 | -1.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering non-invasive testing and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse, and a biosensor platform.
The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
The stock is currently priced at $1.81 per share, with a market capitalization of $4.33M. It ranks 5316 in market capitalization, indicating a small-cap profile. This status is consistent with the modest market cap and low float typical of micro-cap growth names.
A major floor 40.5% below — a decisive break under it would weaken the trend.
The nearest floor, 14.8% below — buyers have tended to step in here.
The nearest ceiling, 30.8% above — a clean break opens room to run.
A major ceiling 125.8% above — clearing it would confirm fresh momentum.
Key INBS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INBS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.65 | Buy | $1.70 | Buy |
| MA 10 | $1.74 | Buy | $1.77 | Buy |
| MA 20 | $1.98 | Sell | $1.92 | Sell |
| MA 50 | $2.23 | Sell | $2.27 | Sell |
| MA 100 | $2.64 | Sell | $3.18 | Sell |
| MA 200 | $5.25 | Sell | $5.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.81 | Neutral |
| Stoch RSI (14) | 72.08 | Neutral |
| CCI (20) | -46.97 | Neutral |
| Williams %R (14) | -64.86 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -20.96 | Sell |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 35.14 | Neutral |
| TRIX (15) | -1.03 | Sell |
| Awesome (5,34) | -0.45 | Sell |
| Ultimate (7,14,28) | 42.20 | Neutral |
| Momentum (10) | -0.30 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 1.58 | Buy |
| ADX (14) | 29.78 | Sell |
| ATR (14) | 0.08 | Info |
The near-term mood is BEARISH, with the RSI14 at 40. This suggests some room for downside before potential stabilization. The 50-day simple moving average is $2.23 and the 200-day simple moving average is $5.25, both above the current price and indicating a bearish longer-term trend.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.55 | $1.82 | $2.37 | 0% | Neutral | |
| $1.24 | $1.65 | $2.36 | -9% | Neutral | |
| $1.17 | $1.63 | $2.46 | -10% | Neutral | |
| $1.05 | $1.53 | $2.41 | -16% | Bearish | |
| $1.15 | $1.73 | $2.83 | -5% | Neutral | |
| $1.30 | $2.03 | $3.41 | +11% | Neutral | |
| $1.38 | $2.22 | $3.84 | +22% | Bullish | |
| $1.40 | $2.32 | $4.11 | +27% | Bullish | |
| $1.27 | $2.16 | $3.92 | +19% | Neutral | |
| $1.18 | $2.07 | $3.83 | +14% | Neutral | |
| $1.52 | $3.07 | $6.18 | +68% | Bullish | |
| $1.83 | $4.06 | $9.23 | +123% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.55 | $1.82 | $2.26 | +0.00% |
| September 2026 | $1.48 | $1.78 | $2.22 | -2.25% |
| October 2026 | $1.46 | $1.77 | $2.25 | -0.27% |
| November 2026 | $1.51 | $1.85 | $2.38 | +4.30% |
| December 2026 | $1.46 | $1.81 | $2.37 | -1.94% |
Click any year to see its month-by-month INBS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INBS to range from $1.55 to $2.37 through 2026. The $1.82 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The INBS price prediction for 2027 points to an average of $1.65 (low $1.24, high $2.36) — a potential decline of -9% on today's $1.82. Price action looks broadly range-bound.
In 2028, INBS is projected to trade between $1.17 and $2.46, averaging $1.63 — a potential decline of -10% from today's $1.82. That is -1% versus the projected 2027 average. A consolidation phase looks the most probable path here.
Intelligent Bio Solutions Inc.'s 2029 outlook centres on $1.53, within a $1.05 to $2.41 range. That is -6% versus the projected 2028 average. That marks a -16% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2030, INBS could reach as high as $2.83, with a base case around $1.73 and support toward $1.15 — roughly -5% from $1.82. A consolidation phase looks the most probable path here.
Expect INBS to range from $1.30 to $3.41 through 2031. The $2.03 average target implies a +11% move from current prices. That is up +17% on the projected 2030 average. Price action looks broadly range-bound.
The INBS price prediction for 2032 points to an average of $2.22 (low $1.38, high $3.84) — a potential gain of +22% on today's $1.82. Buyers look set to stay in control over this stretch.
In 2033, INBS is projected to trade between $1.40 and $4.11, averaging $2.32 — a potential gain of +27% from today's $1.82. That is up +4% on the projected 2032 average. Momentum favours further upside here.
Intelligent Bio Solutions Inc.'s 2034 outlook centres on $2.16, within a $1.27 to $3.92 range. That is -7% versus the projected 2033 average. That marks a +19% change versus current levels. A consolidation phase looks the most probable path here.
By 2035, INBS could reach as high as $3.83, with a base case around $2.07 and support toward $1.18 — roughly +14% from $1.82. Price action looks broadly range-bound.
Expect INBS to range from $1.52 to $6.18 through 2040. The $3.07 average target implies a +68% move from current prices. That is up +48% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The INBS price prediction for 2050 points to an average of $4.06 (low $1.83, high $9.23) — a potential gain of +123% on today's $1.82. Momentum favours further upside here.
Investing $1,000 in INBS today (≈ 549.450549 INBS) could be worth
$2,231.2
+$1,231.2 (+123%) by 2050 · US Dollar
Based on the average projected INBS price of $4.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INBSwould be worth at today's price.
$1,000 invested in INBS on Jul 31, 2025 (≈ 63.291138 INBS) would be worth
$115.19
-$884.81 (-88.5%) today · 0.12× · US Dollar
Based on a INBS entry price of $15.8 vs. today's $1.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.75 | $1,040 | +4.0% |
| 1 month ago | $2.23 | $816.14 | -18.4% |
| 3 months ago | $2.41 | $755.19 | -24.5% |
| 6 months ago | $7.86 | $231.55 | -76.8% |
| 1 year ago | $15.8 | $115.19 | -88.5% |
| All time (5.0y) ago | $7,416 | $0.25 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INBS forecast.
Our base-case forecast reaches $3.60 around 2050.
Implied market cap at $3.60: $8.61M
The forecast for 2026 shows a neutral sentiment with an average price of $1.81 and a min of $1.55 and a max of $2.35, yielding a 0% ROI. In 2027 the neutral view persists with an average of $1.64 (min $1.24, max $2.34) and a -9.3% ROI, followed by 2028 at an average of $1.63 (min $1.17, max $2.45) and a -10.2% ROI. In 2029 the sentiment turns bearish with an average of $1.52 (min $1.04, max $2.39) and a -16.1% ROI, before 2030 again signaling neutral with an avg of $1.72 (min $1.14, max $2.81) and a -4.8% ROI.
From 2031 to 2033 the forecast improves, with 2031 avg $2.02 (min $1.30, max $3.40, ROI 11.7), 2032 avg $2.20 (min $1.37, max $3.81, ROI 21.8), and 2033 avg $2.31 (min $1.39, max $4.09, ROI 27.5). The path remains constructive in the mid-term with 2034 avg $2.15 (min $1.26, max $3.91, ROI 19) and 2035 avg $2.06 (min $1.17, max $3.80, ROI 13.6). The long horizon turns decisively bullish, with 2040 avg $3.05 (min $1.51, max $6.15, ROI 68.7) and 2050 avg $4.03 (min $1.81, max $9.15, ROI 122.6).
These figures imply upside potential over the coming years, but they come with notable volatility and uncertainty, particularly in the near term.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $1.72 with a min of $1.14 and a max of $2.81, and a ROI of -4.8%. The sentiment is NEUTRAL.
The outlook is mixed. Near term (2026–2030) is NEUTRAL with lower highs, while later years 2032–2050 turn BULLISH with higher averages (up to $4.03 by 2050) and positive ROIs, though early years include declines (e.g., 2029 with avg $1.52 and ROI -16.1%). These are estimates, not guarantees.
Yes. The forecast shows 2031 avg $2.02, 2032 avg $2.20, and 2033 avg $2.31, all above $2.00 on average.
Current price is $1.81 and market capitalization is $4.33M.
The 30-day picture shows BEARISH sentiment, with RSI14 at 40. The 50-day SMA is $2.23 and the 200-day SMA is $5.25. Support is at $1.55 and resistance at $2.38, with a 30-day price range of $1.35 to $2.42 and annualized volatility of 80%.
Intelligent Bio Solutions Inc. Community Discussion
0Share your Intelligent Bio Solutions Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.